Captive Owner Q&A: Kevin Steed, AstraZeneca

Fresh from speaking at the Captive Review London Leaders’ Summit 2023 in...
MORE

Steed plans adding “business resilience” cover to 2024 captive programme

AstraZeneca’s head of group insurance says BI losses from non-traditional perils becoming...
MORE

January Editor’s Letter

It was only in January last year that I was attending a...
MORE

R&Q completes second AstraZeneca captive acquisition

AstraZeneca Insurance Company Limited (AZICO), which ceased underwriting in 2004, has been...
MORE

R&Q completes acquisition of AstraZeneca captive

Run-off and legacy solutions specialists, R&Q, have received regulatory approval to complete...
MORE
Group captive specialist Captive Resources has seen more small and mid-sized businesses looking to medical...
MORE
Ian Edward Stafrace from Atlas Insurance PCC shares how innovative cell solutions can simplify cross-border...
MORE
Welcome to the final part of our run-down of the Captive Review 2024 Power 50!...
MORE
We continue our run-down of the most influential people in the captive market today by...
MORE